In addition to our study, our collaborators at UCSF (Perera Lab) published a study in the same edition identifying that NCOA4-mediated ferritinophagy is upregulated in response to MAPK pathway inhibition suggesting a useful combination therapy for pancreatic cancer.
Finally - both of our studies were featured on the cover of the journal (image above - credit to Cancer Discovery) and reviewed in a great preview authored by the Amaravadi Lab.